Brendan O’Grady
CEO
CEO
Other
Other
Board Member
Board Member
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Assertio Holdings, Inc. (ASRT) | CEO | $721,933 | $1,884,984 |
| 2024 | Assertio Holdings, Inc. (ASRT) | CEO | $502,372 | $3,012,703 |
| 2021 | American Well Corp (AMWL) | Chief Commercial and Growth Officer | $181,875 | $8,889,780 |
| 2020 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, NorthAmerica Commercial | $776,923 | $4,126,283 |
| 2019 | Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, NorthAmerica Commercial | $676,923 | $3,462,290 |
Earnings-call appearances
-
Assertio Holdings, Inc. Q2 FY2025 Earnings Call2025-08-11
Assertio Holdings, Inc. (ASRT)
-
Assertio Holdings, Inc. Q1 FY2025 Earnings Call2025-05-12
Assertio Holdings, Inc. (ASRT)
-
Assertio Holdings, Inc. Q4 FY2024 Earnings Call2025-03-12
Assertio Holdings, Inc. (ASRT)
-
Assertio Holdings, Inc. Q3 FY2024 Earnings Call2024-11-11
Assertio Holdings, Inc. (ASRT)
-
Assertio Holdings, Inc. Q2 FY2024 Earnings Call2024-08-07
Assertio Holdings, Inc. (ASRT)